Eubiotics Market Size was valued at USD 5.2 Billion in 2023. The Eubiotics market Livestock is projected to grow from USD 5.6342 Billion in 2023 to USD 9.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.30 % during the forecast period (2024 - 2032). Favourable regulatory scenarios that prohibit the use of antibiotics and increase meat consumption, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Demand for the product is anticipated to be fueled by favorable legal scenarios that ban the use of antibiotics and increased meat consumption worldwide. The market is fiercely competitive, with long-standing companies capturing the majority of the market share. Businesses are spending a lot of money on research and development to develop environmentally friendly manufacturing methods. Due to the dearth of competitors in many countries, especially those in the Middle East, there are several chances for new businesses to enter and build a strong position in the market.
Through feed mills, pre-mixers, or particular distributors, eubiotics are produced and disseminated. Eubiotics are produced by businesses that either offers their goods directly to consumers or to integrated feed producers. In any case, the animal farmers receive the eubiotic products. Eubiotics are produced using techniques like fermentation and chemical synthesis to create organic acids, for example. For the most part, chemical synthesis is preferred for uses in animal feed, such as silage and feed additives. The availability of raw materials, agroclimatic conditions, regional jurisdictions, etc. have a significant impact on eubiotics pricing. Due to the existence of buyers who are price sensitive, producers compete based on competitive pricing. To achieve a competitive edge in the market, businesses are concentrating on process innovation and low-cost raw material sourcing. Additionally, it is anticipated that prices will rise somewhat throughout the forecast period due to the rapid expansion of end-use industries like feed and pharmaceuticals as well as rising eubiotic production, which is prone to close the supply-demand imbalance.
Prebiotics and probiotics are examples of eubiotic products that play a significant role in the nutraceuticals industry's value chain. The market is well-positioned for emerging nations like India and China because of advances in technology, the availability of low-cost labour, and upscale production of raw materials. Therefore, major firms in developing economies are setting up an efficient manufacturing process and a solid supply chain to produce goods cheaply and provide them at prices that are comparably lower.
Eubiotics is currently seeing a large rise since it helps to increase both the amount and quality of animal products produced. The demand for eubiotic feed is growing as people's understanding of the benefits of eubiotics for animals and their concerns for the health of animals grow. As a result, the poultry industry is seeing an increase in the need for eubiotics, which are used to improve feed utilisation, bird egg production, and illness prevention. Growing consumer awareness of the health advantages of eubiotic additives for farm animals is anticipated to fuel market growth for eubiotics during the assessment period. This is a result of eubiotics' high quality, which is increasing people's awareness of feed addiction. A broad market penetration is also being created worldwide by the introduction of novel items including organic acids, prebiotics, and probiotic feed additives. As a result, the market is expanding rapidly. Thus, driving the Eubiotics market revenue.
The Eubiotics market segmentation, based on Form, includes Liquid and Dry. Dry segment dominated the market in 2022. Its advantages, such as enhanced defense against exposure to light and moisture, account for this significant proportion. Solid forms include flakes, beadlets, and cross-linked beadlets. When used in the production of feed, beadlet technology successfully protects the active ingredients from heat and mechanical stress, increasing their stability and bioavailability.
The Eubiotics market segmentation, based on Type, includes Prebiotics, Probiotics, and Others. Probiotics segment dominated the Eubiotics market in 2022. This is attributed to rising consumer knowledge of the use of probiotics in animal feed, ongoing R&D work to provide practical solutions, and broad product portfolios provided by significant industry participants. The numerous animal applications, such as immune boosting and gut health maintenance, are also projected to have a favorable impact on market demand.
The Eubiotics market segmentation, based on Function, includes General Health & Wellness, Immunity, Gut & Digestive Health, and Others. Gut & digestive health segment dominated the Eubiotics market in 2022. Its significant market share can be linked to the fact that digestive issues in animals are a common occurrence as well as the growing acceptance of preventative healthcare. Eubiotic solutions help animals' digestive and immunological systems by aggregating the microbial production in their gastrointestinal tracts.
The Eubiotics market segmentation, based on Livestock, includes Aquatic, Poultry, Ruminants, Swine, and Others. Poultry segment dominated the market in 2022. It has a sizable market share because of the growing demand for and consumption of chicken, turkey, duck, and boilers. Chicken meat is one of these that is often consumed due to its reasonable pricing when compared to others, low fat content, and fewer religious & cultural limitations associated with its ingestion.
Figure 1: Eubiotics Market, by Livestock, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Eubiotics Market dominated this market in 2022 (45.80%). This is a result of both the rapidly expanding animal feed business and the increased demand for animal goods. Increased awareness of animal health due to the expanding consumption of meat and meat products in nations like Mexico, Canada, and the U.S. has reinforced the market for animal feed products. Further, the U.S. Eubiotics market held the largest market share, and the Canada Eubiotics market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: EUBIOTICS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Eubiotics market accounted for the healthy market share in 2022. This is brought on by an increase in meat consumption and production, which comes from processed meals. In recent years, meat consumption has rapidly increased in countries like Italy, France, and Germany. As a result, producers are now searching for high-quality, disease-free animal products. Further, the German Eubiotics market held the largest market share, and the U.K Eubiotics market was the fastest growing market in the European region
The Asia Pacific Eubiotics market is expected to register significant growth from 2023 to 2032. The demand for feed additives was sparked by the necessity to focus on the sanitation and health of animals due to the rising consumption of meat and meat products. One of the key factors influencing the demand for animal feed and additives in the region is the increase in beef and pork consumption in Japan, China, India, and South Korea. Moreover, China’s Eubiotics market held the largest market share, and the Indian Eubiotics market was the fastest growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Eubiotics market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Eubiotics Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Eubiotics Industry to benefit clients and increase the market sector. In recent years, the Eubiotics Industry has offered some of the most significant advantages to medicine. Major players in the Eubiotics market, including Koninklijke DSM N.V., EI. du Pont de Nemours and Company, BASF SE, Cargill Inc., Chr Hansen Holding A/S, Novozymes A/S, Kemin Industries Inc., Calpis Co. Ltd., Behn Meyer Holding AG, and Lallemand Inc., are attempting to increase market demand by investing in research and development operations.
To identify environmental, social, and economic challenges and opportunities, seize those opportunities to have a long-lasting positive impact on people and the environment, and then build growth through sustainable, profitable expansion, is the mission of Royal DSM NV (DSM), a science-based company. Specialty polymers, fiber and resin products, nutritious lipids, carotenoids, vitamins, and other components are produced by the company. The business manufactures materials for medical devices and renewable energy out of agricultural waste and biochemicals. The business closely coordinates its activities with those of its customers to encourage the rapid development of important science-based innovations. The company has operations in Eastern Europe, Latin America, North America, Asia Pacific, and other regions. DSM is based in the Dutch province of Heerlen in the Limburg region. In July 2021, Koninklijke DSM NV (Royal DSM) acquired Midori USA Inc., a start-up company specializing in developing customized eubiotics that enhance animal welfare and environmental impact.
Novus International creates animal nutrition products in Saint Charles, Missouri. In order to meet the growing need for nutrition and health on a scale, the company additionally produces methionine and provides solutions for cattle, poultry, and aquaculture. In 2021, Novus International teamed up with the American biotechnology company Agrivida for joint R&D initiatives. This arrangement will allow the company to investigate potential new product innovations that might support the eubiotics market.
Eubiotics Industry Developments
January 2023: Cargill and BASF stated they were extending their collaboration in feed enzyme distribution and development to include the United States. The companies want to establish a collaborative innovation pipeline that would serve the region's producers of animal protein, who are battling to meet the rising demand for animal protein.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 5.2 Billion |
| Market Size 2024 | USD 5.6342 Billion |
| Market Size 2032 | USD 9.9 Billion |
| Compound Annual Growth Rate (CAGR) | 7.30% (2024-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Form, Type, Function, Livestock, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Koninklijke DSM N.V., EI. du Pont de Nemours and Company, BASF SE, Cargill Inc., Chr Hansen Holding A/S, Novozymes A/S, Kemin Industries Inc., Calpis Co. Ltd., Behn Meyer Holding AG, and Lallemand Inc. |
| Key Market Opportunities | Increasing investments and opportunities in animal nutrition |
| Key Market Dynamics | Favorable regulatory scenarios banning the usage of antibiotics and growing meat consumption across the globe |
Eubiotics Market Highlights:
Frequently Asked Questions (FAQ) :
The Eubiotics market size was valued at USD 4.8 Billion in 2022.
The market is projected to grow at a CAGR of 7.30% during the forecast period, 2024-2032.
North America had the largest share in the market
The key players in the market are Koninklijke DSM N.V., EI. du Pont de Nemours and Company, BASF SE, Cargill Inc., Chr Hansen Holding A/S, Novozymes A/S, Kemin Industries Inc., Calpis Co. Ltd., Behn Meyer Holding AG, and Lallemand Inc.
The Dry Form dominated the market in 2022.
The Probiotics Type had the largest share in the market.
Research Analyst Level II I have about two years of experience working in the consumer goods and retail industries and i am a biotech graduate.a tech-savvy analytically focused professional with a strong capabilities in identification, concept generation, and strategy evaluation. i can produce data-driven solutions while fusing unusual viewpoints with original concepts. i have been extensively working on business case studies, competitive & comparative analyses, and strategic reports. my primary areas of experience include client management, financial analysis, supply chain evaluation, market entry strategy evaluation, and estimating and forecasting market size.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
